14 August 2024 false No description of principal activity Taxfiler 2024.6 15897162business:PrivateLimitedCompanyLtd2024-08-142025-08-31 158971622024-08-13 158971622024-08-142025-08-31 15897162business:AuditExempt-NoAccountantsReport2024-08-142025-08-31 15897162business:FilletedAccounts2024-08-142025-08-31 158971622025-08-31 15897162business:Director12024-08-142025-08-31 15897162business:RegisteredOffice2024-08-142025-08-31 15897162core:WithinOneYear2025-08-31 15897162core:ShareCapitalcore:PreviouslyStatedAmount2025-08-31 15897162core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2025-08-31 15897162core:PreviouslyStatedAmount2025-08-31 15897162business:SmallEntities2024-08-142025-08-31 15897162countries:EnglandWales2024-08-142025-08-31 iso4217:GBP xbrli:pure
Company Registration No. 15897162 (England and Wales)
Akh Pharma Limited Unaudited accounts for the period from 14 August 2024 to 31 August 2025
Akh Pharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Akh Pharma Limited Company Information for the period from 14 August 2024 to 31 August 2025
Director
Aadam Khalid Hadrami
Company Number
15897162 (England and Wales)
Registered Office
2 Daniel Hill Terrace Sheffield S6 3JE England
Accountants
Asad Hanif AFA MIPA 376 LANGSETT ROAD SHEFFIELD S6 2UG
- 3 -
Akh Pharma Limited Statement of financial position as at 31 August 2025
2025 
Notes
£ 
Current assets
Cash at bank and in hand
5,288 
Creditors: amounts falling due within one year
4
(2,432)
Net current assets
2,856 
Net assets
2,856 
Capital and reserves
Called up share capital
1 
Profit and loss account
2,855 
Shareholders' funds
2,856 
For the period ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 13 January 2026 and were signed on its behalf by
Aadam Khalid Hadrami Director Company Registration No. 15897162
- 4 -
Akh Pharma Limited Notes to the Accounts for the period from 14 August 2024 to 31 August 2025
1
Statutory information
Akh Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15897162. The registered office is 2 Daniel Hill Terrace, Sheffield, S6 3JE, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2025 
£ 
Taxes and social security
670 
Loans from directors
1,362 
Accruals
400 
2,432 
5
Average number of employees
During the period the average number of employees was 0.
- 5 -